Title: FL Life Sci Funding: Challenges & Solutions for CFOs

Speakers:  

1. Dr. Leandro Christmann, VP of Venture & Investments at Moffitt Cancer Center.
2. Patrick McCauley JD, MBA, CEO of ThirdOpinion, a company dedicated to empowering patients through personalized healthcare insights. He is also a member of the BioFlorida Leadership Team, contributing to the advancement of the life sciences industry in Florida. With a strong background in law and business, Patrick is committed to driving innovation and collaboration in healthcare and biotechnology.
3. Mohan Srinivasan, financial executive with expertise in corporate strategy and public market transitions. As CFO of Trulieve Cannabis Corp., he guided the company through a successful public listing, showcasing his leadership in complex, high-growth industries.

Dress Code: Business Attire

Join us for our 3rd and final in-person gathering of 2024, an engaging event focused on funding insights and opportunities within Florida’s life sciences sector. Network with peers and gain valuable perspectives from industry leaders on navigating the current funding landscape.  

Preliminary Discussion Focus:  

•  Limited Capital Sources: Florida's small life sciences VC pool pushes CFOs to seek funding from national investors, lengthening funding cycles and increasing dilution risks.
• Grant Dependence: Florida's limited and competitive grant landscape creates budget uncertainties, requiring diversified funding strategies and careful cash flow management.
• Talent Costs: Recruiting skilled life sciences professionals often means high relocation and compensation costs, impacting budgets and long-term financial planning.
• Early-Stage Funding Gaps: There’s a scarcity of early-stage funding specific to life sciences, making it challenging for startups to bridge the gap between R&D and later-stage investment, putting pressure on CFOs to stretch initial capital further.
• Market Validation and Scalability: Florida life sciences companies face challenges in accessing nearby pilot programs, testing facilities, and partnerships for market validation, which can delay scalability and revenue generation. CFOs need to plan for extended timelines and allocate resources for out-of-state collaborations if needed.

These issues require Florida CFOs to focus on long-term budgeting, securing diverse funding sources, and developing strategic partnerships.

**Please RSVP to secure your spot and mark your calendar.** Further details on our panelists and discussion topics will be shared soon.

Link and Bio:

Dr. Leandro Christmann a seasoned life sciences executive with over two decades of experience in biotechnology and healthcare. He has held pivotal roles in organizations such as AviGenics, Synageva BioPharma, and the Allen Institute, focusing on transgenic avian development, protein therapeutics, and strategic partnerships, respectively. In February 2024, Dr. Christmann was appointed as Vice President of Ventures and Investments at Moffitt Cancer Center, where he leads initiatives to advance Moffitt's innovative research through strategic partnerships and commercialization efforts.

https://www.linkedin.com/in/leandro-christmann/

Patrick McCauley, Leveraging a career marked by excellence in the biopharmaceutical and life sciences industry, I am an agile and authentic executive that is known for building strong commercial teams and launching innovative products – and positioning both as market leaders in a highly competitive business landscape.

https://www.linkedin.com/in/patrick-mccauley-jd-mba/

Mohan Srinivasan, CFO Public Company /Corporate Director/ Senior Financial Executive/Strategic Finance Leader - Interested in concluding a liquidity transaction - IPO or integration and sale after roll up, consolidation and ERP implementation.

https://www.linkedin.com/in/mohan-srinivasan-5800932/